8 results
6-K
EX-99.2
LNDZF
Salona Global Medical Device Corporation
12 Aug 24
Condensed Consolidated Interim Financial Statements
6:58pm
nuclear medicine products.
In April 2023, pursuant to the earnout provisions of the acquisition agreement, the Company issued the Simbex sellers
6-K
EX-99.2
LNDZF
Salona Global Medical Device Corporation
31 May 24
Condensed Consolidated Interim Financial Statements
9:13pm
of the Biodex Physical Medicine business and a contract manufacturing agreement to manufacture nuclear medicine products.
In April 2023, pursuant
8-K
EX-99.1
LNDZF
Salona Global Medical Device Corporation
10 Aug 23
Salona Global Extends Biodex Acquisition Debt Duration to July 2025
5:21pm
included (i) approximately US$1.5 miilion payable under a loan for nuclear medicine medical device inventory and parts which was due May 15, 2023; (ii
8-K
EX-10.1
LNDZF
Salona Global Medical Device Corporation
10 Aug 23
Salona Global Extends Biodex Acquisition Debt Duration to July 2025
5:21pm
proper management of the Nuclear Imaging business. This includes in particular:
(i) Accurate Lead Times updated on a monthly basis
(ii) Promise dates
8-K
EX-99.1
65qz xv5v1vtn
27 Jul 23
Departure of Directors or Certain Officers
6:12pm
8-K
EX-2.1
ytifty
5 Dec 22
Entry into a Material Definitive Agreement
4:34pm
8-K
EX-99.1
dfuleh
5 Dec 22
Entry into a Material Definitive Agreement
4:34pm
- Prev
- 1
- Next